Response to General revision of Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in application of Articles 107 and 108 of the Treaty (‘General Block Exemption Regulation’)

6 Oct 2025

Meeting with András Tivadar Kulja (Member of the European Parliament)

17 Sept 2025 · Cardiovascular diseases, oncology, pain/inflammation, asthma

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur) and Pro Generika e.V.

16 Sept 2025 · Critical Medicines Act

Response to Commission Communication on a EU Cardiovascular Health Plan

15 Sept 2025

Meeting with Alessandra Moretti (Member of the European Parliament)

4 Sept 2025 · Critical Medicine Act

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur) and 3 other interest representatives

17 Jul 2025 · Critical Medicines Act

Meeting with Mohammed Chahim (Member of the European Parliament, Shadow rapporteur for opinion)

11 Jul 2025 · Critical Medicines Act (follow up)

Meeting with Mohammed Chahim (Member of the European Parliament, Shadow rapporteur for opinion) and 14 other interest representatives

25 Jun 2025 · Roundtable Critical Medicines Act

Meeting with Francesco Torselli (Member of the European Parliament, Shadow rapporteur for opinion)

21 May 2025 · Incontro conoscitivo

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur) and BGP Products Operations GmbH – a Viatris Company

13 May 2025 · Health policy

Meeting with András Tivadar Kulja (Member of the European Parliament)

24 Apr 2025 · Critical medicines act

Meeting with Nicolás González Casares (Member of the European Parliament)

8 Apr 2025 · Health

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and 9 other attendees

4 Apr 2025 · Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with Aurelijus Veryga (Member of the European Parliament)

2 Apr 2025 · Discussion on the Critical Medicines Act and its role in improving medicine availability and supporting EU-based manufacturing

Meeting with Giulia Del Brenna (Head of Unit Internal Market, Industry, Entrepreneurship and SMEs)

18 Mar 2025 · Menarini, a €3 billion revenue pharmaceutical manufacturer, mostly active in the generic medicines domain, wanted to discuss the recently adopted Commission proposal for a Critical Medicines Act (CMA), and provide some first reactions.

Meeting with Susanna Ceccardi (Member of the European Parliament)

21 Feb 2024 · Meeting with Menarini Group

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

23 Jan 2024 · Pharmaceutical legislation

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and AbbVie

18 Dec 2023 · Revision of Pharmaceutical Package (staff level)

Meeting with Nicola Danti (Member of the European Parliament) and Associazione delle Imprese del farmaco

7 Nov 2023 · Posizione su revisione pacchetto farmaceutico

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

3 Nov 2023 · Pharmaceutical Package, AMR

Meeting with Patrizia Toia (Member of the European Parliament)

19 Apr 2023 · Pharmaceutical Strategy